[Effect of doxycycline on the development of pulmonary hypertension induced by four methods in rats]

Kun Shi1, Li-Na Qiao, Bin Liu

  • 1Department of Pediatric Cardiology, West China Second Hospital, Sichuan University, Chengdu 610041, China.

Abstract

Insights

Doxycycline treatment effectively reduced pulmonary hypertension (PH) and pulmonary vascular remodeling in rat models. This suggests matrix metalloproteinases (MMPs) play a key role in PH development across various etiologies.

Area of Science:

  • Cardiovascular Research
  • Pulmonary Medicine
  • Pharmacology

Context:

  • Pulmonary hypertension (PH) is a severe condition characterized by elevated pressure in the pulmonary arteries.
  • Pulmonary vascular remodeling, including vascular wall thickening and increased muscularization, contributes significantly to PH.
  • Matrix metalloproteinases (MMPs) are implicated in tissue remodeling, but their specific role in PH development requires further elucidation.

Purpose:

  • To investigate the inhibitory effect of doxycycline on matrix metalloproteinases (MMPs).
  • To evaluate the impact of doxycycline on the development of experimental pulmonary hypertension (PH) and associated pulmonary vascular remodeling in rat models.
  • To explore the role of MMPs in various etiologies of PH.

Summary:

  • Four rat models of experimental PH were established and treated with doxycycline (20 mg/kg daily).
  • Doxycycline administration significantly attenuated mean pulmonary arterial pressure (mPAP), right ventricular hypertrophy (Fulton Index), vascular wall thickness, and smooth muscle proliferation in pulmonary arterioles.
  • Gelatin zymography confirmed that doxycycline effectively inhibited MMP activity, including MMP2, in lung tissues.

Impact:

  • Doxycycline demonstrated a therapeutic effect in mitigating PH and pulmonary vascular remodeling across different experimental models.
  • The findings highlight the crucial role of high expression and enhanced activity of MMPs in the pathogenesis of PH.
  • This study provides evidence for a common mechanism underlying PH development, irrespective of the initial etiological factors, suggesting potential therapeutic targets.

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...